Wednesday, March 15, 2017 10:41:25 PM
http://aheadoftheherd.com/Newsletter/2016/Imagin-Medical.htm
Also an update from President and CEO Jim Hutchens:
http://aheadoftheherd.com/Advertising/Sponsor_Page/ImaginMedical/index.html
Also the news release about the financing obtained:
Financing Drawdown Facility
Imagin announced, on the 22nd of February, that it has executed a non-binding term sheet with Alumina Partners. The understanding provides for a series of private placement offerings, over a 24 month period, to be conducted between the Company and Alumina Partners.
“We were impressed by the quality and pace of the ongoing clinical research supporting Imagin’s i/Blue system and, unusual for the emerging growth space, by its lofty academic pedigree as well. Jim Hutchens and his team of industry veterans are poised to substantially change the way we approach bladder cancer – the fourth most common cancer among men and by far the most expensive to treat. For a company of their size to credibly even have a chance of contributing to the fight against cancer is nothing short of extraordinary. We at Alumina are proud to support innovators like Imagin Medical, and we look forward to seeing what they accomplish in the year to come.” Adi Nahmani, Managing Member of Alumina Partners
As part of the Alumina Financing Cdn$125,000.00 has been drawn from the facility. Imagin also conducted a Cdn$100,000.00 financing in which the company’s president and two directors invested Cdn$60,000.00.
To sum it all up iblue will be on humans shortly, the company is financed through FDA approval and commercialization and insiders have taken part in financing the company.
Richard (Rick) Mills
aheadoftheherd.com
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM